Europe Fetal and Neonatal Monitoring Market - Growth, Trends, and Forecasts (2023-2028)

The Europe fetal and neonatal monitoring market is expected to register a CAGR of 6.2% over the forecast period.

COVID-19 had a significant impact on the growth of the market owing to the strict regulation imposed on the European population. Due to such stringent regulations, the demand for fetal and neonatal monitors was impacted during the initial phase of the pandemic outbreak. Though newborns are at lower risk of developing COVID-19 infection, the utmost care, and monitoring are required, which involves continuous monitoring of blood oxygen levels and heartbeat. Thus, the COVID-19 pandemic has boosted the demand for fetal and neonatal monitoring, and the market is expected to follow the same traction during the forecast period of the study.

Fetal and neonatal monitoring devices are vital tools that are routinely used in gynecology and obstetrics interventions to examine fetal health during labor and delivery. These devices are thus designed for the unique needs of newborn babies. The prevalence of preterm births has increased in recent decades, and these preterm newborns are found to be prone to various diseases and infections. For instance, according to the research article published in the European Journal of Pediatrics, in 2021, the estimated rate of preterm births in Europe was 8.7, which is one of the major causes of death in early childhood in the region. Preterm babies often require special care in the neonatal intensive care unit (NICU), owing to which the demand for neonatal devices is also increasing, which is expected to act as a key driving force for the studied market.

Additionally, the increasing strategic activities by various market players, such as product launches and developments coupled with awareness activities in Europe regarding fetal and neonatal monitoring, are also expected to contribute to the growth of the market over the forecast period. For instance, in May 2021, Medtronic plc launched the SonarMed airway monitoring system. The Sonarmed airway monitoring system utilizes acoustic technology to check for endotracheal tube obstruction and verify position in real-time, giving clinicians vital information required to make more informed, life-saving decisions for Neonates and Infants. Moreover, in March 2022, International Patient Organization for Primary Immunodeficiency (IPOPI) and International Society for Neonatal Screening (ISNS), and the European Society for Immunodeficiencies (ESID) launched the Screen4Rare website. It is a multi-stakeholder platform aiming to exchange knowledge and best practices on newborn screening for rare diseases. Such launches by various organizations are expected to increase awareness among the European population regarding fetal and neonatal health monitoring, thereby contributing to the growth of the market. Hence, these newborns are kept under surveillance using monitoring equipment. These factors have increased the demand for monitoring devices and equipment, which has also driven technological advancements in the equipment.

Thus, the high prevalence of preterm births, frequent product launches, and rising awareness among the European population are expected to fuel the growth of the market over the forecast period. However, the regulatory guidelines for market approval are also very stringent, which dissuades many manufacturers from entering the region.

Europe Fetal & Neonatal Monitoring Market Trends

Pulse Oximeters Segment is Expected to Hold Significant Share in the Market Over the Forecast Period

A pulse oximeter is a device that is used to estimate the oxygen saturation of the blood and pulse rate in neonates. Pulse Oximetry screening is done after 24 hours after birth to allow the baby's heart and lungs to fully adjust to life outside the birth mother. This is a vital instrument in the care of infants and children with cardio-pulmonary disease. Factors such as the high burden of diseases among neonates and the growing demand for early diagnosis are also expected to drive the growth of the studied segment. For instance, as per the NCBI article published in April 2022, neonatal screening in Germany currently comprises 19 congenital diseases, 13 of which are metabolic diseases. Approximately 1300 newborns suffer from one of these target diseases. Therefore, the high risk of diseases in neonatal and the incidence of preterm births in the region is boosting the segment growth.

The increasing awareness and advanced product launches in this region are anticipated to boost segment growth over the forecast period. For instance, in November 2021, Masimo launched the Dual SET pulse oximetry for root, a versatile patient monitoring and connectivity hub. The first application of Dual SET oximetry is a significant advancement for critical congenital heart disease in newborns. Additionally, in February 2021, Medtronic plc completed its study on Newborns using Nellcor Pulse Oximetry Technology and revealed that a stable signal was obtained from all 60 newborns with the Nellcor pulse oximeter, thus suggesting this device is a simple, noninvasive bedside monitoring device for neonates in the detection of oxygen saturation levels and heart rate. Thus, owing to the aforementioned factors, rising demand for pulse oximeters, and the launch of advanced products, the studied segment is expected to register a notable CAGR over the forecast period in the region.

United Kingdom is Expected to Hold the Significant Share in the Market Over the Forecast Period

The United Kingdom is expected to hold a significant share in the Europe fetal and neonatal monitoring market over the forecast period owing to the rising number of births and favorable government policies, and increasing awareness campaigns regarding neonatal healthcare. For instance, according to the Office for National Statistics data published in 2022, there were 625,008 live births in 2021, an increase of 1.5% from 615,557 live births in 2020. Such an increase in birth is expected to boost the demand for fetal and neonatal monitoring systems in the United Kingdom.

Moreover, the rising number of favorable policies for fetal and neonatal care and awareness campaigns in the United Kingdom are expected to fuel the growth of the market in this country. For instance, in September 2022, Dentsu UK&I launched a dedicated policy designed to support parents of babies born prematurely or critically ill and receiving neonatal care in the hospital, enabling them to spend more time together. Also, in September 2021, a Neonatal Intensive Care Unit awareness campaign was conducted in the United Kingdom to raise awareness of neonatal care and support impacted families. Hence, owing to the aforementioned factors, such increase in the birth rate and favorable policies, the studied market is expected to witness growth over the forecast period in the region.

Europe Fetal & Neonatal Monitoring Market Competitor Analysis

The Europe fetal and neonatal monitoring market is fragmented, with several players in the market. Some of the strategies implemented include agreements, collaborative models, business expansion, and product development. Some of the major players are Draegerwerk AG & Co. KGaA, FUJIFILM SonoSite Inc., Medtronic Plc, and Koninklijke Philips NV.

Additional benefits of purchasing the report:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.